Published on in Vol 20, No 11 (2018): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11602, first published .
A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial

A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial

A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial

Journals

  1. Ananthakrishnan A, Singh S. The Doctor Will Call You Now! Telemedicine in the Midst of a Pandemic. Clinical Gastroenterology and Hepatology 2020;18(8):1688 View
  2. Del Hoyo J, Nos P, Faubel R, Bastida G, Muñoz D, Valero-Pérez E, Garrido-Marín A, Bella P, Peña B, Savini C, Aguas M. Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups. International Journal of Environmental Research and Public Health 2020;17(6):1871 View
  3. Del Hoyo J, Aguas M. Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?. Gastroenterología y Hepatología 2020;43(8):415 View
  4. Yin A, Hachuel D, Pollak J, Scherl E, Estrin D. Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review. Journal of Medical Internet Research 2019;21(8):e14630 View
  5. Coenen S, Nijns E, Weyts E, Geens P, Van den Bosch B, Vermeire S, Ferrante M, Vanhaecht K, Van Assche G. Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy. Scandinavian Journal of Gastroenterology 2020;55(3):287 View
  6. Rohde J, Barker J, Noar S. Impact of eHealth technologies on patient outcomes: a meta-analysis of chronic gastrointestinal illness interventions. Translational Behavioral Medicine 2021;11(1):1 View
  7. George L, Cross R. Remote Monitoring and Telemedicine in IBD: Are We There Yet?. Current Gastroenterology Reports 2020;22(3) View
  8. George L, Dominic M, Cross R. Integration of telemedicine into clinical practice for inflammatory bowel disease. Current Opinion in Gastroenterology 2020;36(4):304 View
  9. Del Hoyo J, Nos P, Bastida G, Faubel R, Muñoz D, Garrido-Marín A, Valero-Pérez E, Bejar-Serrano S, Aguas M. Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis. Journal of Medical Internet Research 2019;21(9):e15505 View
  10. D’Amico F, Netter P, Baumann C, Veltin M, Zallot C, Aimone-Gastin I, Danese S, Peyrin-Biroulet L. Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience. Journal of Clinical Medicine 2020;9(9):2697 View
  11. Khorshid M, Bakheet N, Abdallah S, Essam M, Cordie A. COVID‐19: A strong call for remote medicine in inflammatory bowel disease. Journal of Digestive Diseases 2020;21(10):597 View
  12. Davis S, Ross M, Adatorwovor R, Wei H. Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review. Research in Nursing & Health 2021;44(1):155 View
  13. Del Hoyo J, Aguas M. Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?. Gastroenterología y Hepatología (English Edition) 2020;43(8):415 View
  14. Spagnuolo R, Corea A, Napolitano D, Nisticò E, Pagnotta R, Pagliuso C, Schiavoni E, Turchini L, Fiorino G, Radice S, Armuzzi A, Doldo P. Nursing‐sensitive outcomes in adult inflammatory bowel disease: A systematic review. Journal of Advanced Nursing 2021;77(5):2248 View
  15. Iqbal F, Lam K, Joshi M, Khan S, Ashrafian H, Darzi A. Clinical outcomes of digital sensor alerting systems in remote monitoring: a systematic review and meta-analysis. npj Digital Medicine 2021;4(1) View
  16. Bonnaud G, Haennig A, Altwegg R, Caron B, Boivineau L, Zallot C, Gilleta de Saint-Joseph C, Moreau J, Gonzalez F, Reynaud D, Faure P, Aygalenq P, Combis J, Peyrin-Biroulet L. Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2021;56(5):530 View
  17. Solitano V, Alfarone L, D’Amico F, Peyrin-Biroulet L, Danese S. IBD goes home: from telemedicine to self-administered advanced therapies. Expert Opinion on Biological Therapy 2022;22(1):17 View
  18. Pinto S, Loddo E, Paba S, Favale A, Chicco F, Onali S, Usai P, Fantini M. Crohn’s disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic. Journal of Patient-Reported Outcomes 2021;5(1) View
  19. Casellas F, González-Lama Y, Ginard Vicens D, García-López S, Muñoz F, Marín Sánchez L, Camacho L, Cabez A, Fortes P, Gómez S, Bella Castillo P, Barreiro-de Acosta M. Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document. Revista Española de Enfermedades Digestivas 2021 View
  20. Costantino A, Bortoluzzi F, Giuffrè M, Vassallo R, Montalbano L, Monica F, Canova D, Checchin D, Fedeli P, Marmo R, Elli L. Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO). Digestive and Liver Disease 2021;53(10):1221 View
  21. Wilke E, Reindl W, Thomann P, Ebert M, Wuestenberg T, Thomann A. Effects of yoga in inflammatory bowel diseases and on frequent IBD-associated extraintestinal symptoms like fatigue and depression. Complementary Therapies in Clinical Practice 2021;45:101465 View
  22. He Z, Wang Z, Song Y, Liu Y, Kang L, Fang X, Wang T, Fan X, Li Z, Wang S, Bai Y. The Reliability and Quality of Short Videos as a Source of Dietary Guidance for Inflammatory Bowel Disease: Cross-sectional Study. Journal of Medical Internet Research 2023;25:e41518 View
  23. Pang L, Liu H, Liu Z, Tan J, Zhou L, Qiu Y, Lin X, He J, Li X, Lin S, Ghosh S, Mao R, Chen M. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of Medical Internet Research 2022;24(3):e28978 View
  24. Vinay G. Increased Self-medication with Steroids in Inflammatory Bowel Disease Patients during COVID-19 Pandemic: Time to Optimize Specialized Telemonitoring Services. Euroasian Journal of Hepato-Gastroenterology 2021;11(2):103 View
  25. Del Hoyo J, Millán M, Garrido-Marín A, Aguas M. Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers. World Journal of Gastroenterology 2023;29(7):1139 View
  26. Costantino A, Caprioli F, Elli L, Roncoroni L, Stocco D, Doneda L, Nandi N, Conforti F, Noviello D, Penagini R, Vecchi M. Determinants of patient trust in gastroenterology televisits: Results of machine learning analysis. Informatics in Medicine Unlocked 2022;29:100867 View
  27. Majidova K, Handfield J, Kafi K, Martin R, Kubinski R. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes 2021;12(10):1465 View
  28. Gohil S, Majd Z, Sheneman J, Abughosh S. Interventions to improve medication adherence in inflammatory bowel disease: A systematic review. Patient Education and Counseling 2022;105(7):1731 View
  29. Spartz E, DeDecker L, Le D, Jalilian L, Limketkai B. Advances in Mobile Health for Inflammatory Bowel Disease. Diagnostics 2022;13(1):37 View
  30. Wong E, Hasan B, Dulai P, Marshall J, Reinisch W, Narula N. End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis. Scandinavian Journal of Gastroenterology 2023;58(1):7 View
  31. Mclaren S, Jhamb M, Unruh M. Using Patient-Reported Measures to Improve Outcomes in Kidney Disease. Blood Purification 2021;50(4-5):649 View
  32. Almario C, Kogan L, van Deen W, Scott F, Singh S, Hou J, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar M, Mize C, Ostrov A, Shah S, Younes Z, Weaver S, Heller C, Siegel C, Melmed G. Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. American Journal of Gastroenterology 2021;116(12):2459 View
  33. Rohde J, Fisher E, Boynton M, Freelon D, Frohlich D, Barnes E, Noar S. A Self-management SMS Text Messaging Intervention for People With Inflammatory Bowel Disease: Feasibility and Acceptability Study. JMIR Formative Research 2022;6(5):e34960 View
  34. Nguyen N, Martinez I, Atreja A, Sitapati A, Sandborn W, Ohno-Machado L, Singh S. Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review. American Journal of Gastroenterology 2022;117(1):78 View
  35. Yao J, Fekadu G, Jiang X, You J, Pittet V. Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic—A cost-effectiveness analysis. PLOS ONE 2022;17(4):e0266464 View
  36. Karami H, Shirvani Shiri M, Ebadi Fard Azar F, Bagheri Lankarani K, Ghahramani S, Rezapour A, Tatari M, Heidari Javargi Z. Factors associated with health-related quality of life in patients with Crohn's disease in Iran: A prospective observational study. Frontiers in Medicine 2023;9 View
  37. Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, Bracewell K, Akobeng A. Remote care through telehealth for people with inflammatory bowel disease. Cochrane Database of Systematic Reviews 2023;2023(5) View
  38. Squires S, Cund A. Digital Technology to Improve Consultation in IBD Care: a Literature Review. Gastrointestinal Nursing 2023;21(4):22 View
  39. Karami H, Azar F, Lankarani K, Rezapour A, Ghahramani S, Baghbanian A. Adalimumab versus Infliximab Treatment Outcome in Ulcerative Colitis: Application of EQ-5D, Visual Analogue Scale, and IBDQ-9 Measures: A Prospective Observational Study. Current Drug Safety 2023;18(4):484 View
  40. Gravina A, Pellegrino R, Durante T, Palladino G, D'Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?. World Journal of Methodology 2023;13(4):194 View
  41. Fantini M, Loddo E, Di Petrillo A, Onali S. Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review. Digestive and Liver Disease 2024;56(1):1 View
  42. Iizawa M, Hirose L, Nunotani M, Nakashoji M, Tairaka A, Fernandez J. A Systematic Review of Self-Management Interventions for Patients with Inflammatory Bowel Disease. Inflammatory Intestinal Diseases 2023;8(1):1 View
  43. Kuriakose Kuzhiyanjal A, Nigam G, Antoniou G, Farraye F, Cross R, Limdi J. Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis 2023;17(10):1596 View
  44. Al-jabri R, Wetwittayakhlang P, Lakatos P. Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities. Journal of Clinical Medicine 2023;12(23):7343 View
  45. King K, McGuinness S, Watson N, Norton C, Chalder T, Czuber-Dochan W. What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials. Patient Preference and Adherence 2023;Volume 17:3265 View
  46. Pacheco M, Sá P, Santos G, Boa-Sorte N, Domingues K, Assis L, Silva M, Oliveira A, Santos D, Ferreira J, Fernandes R, Fortes F, Rocha R, Santana G, Chuang W. Impact of an intervention program on drug adherence in patients with ulcerative colitis: Randomized clinical trial. PLOS ONE 2023;18(12):e0295832 View
  47. Gu Z, Gu J, Liu P. The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic review. BMC Gastroenterology 2024;24(1) View
  48. Amiesimaka O, Aluzaite K, Braund R, Schultz M. Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review. Patient Preference and Adherence 2024;Volume 18:905 View
  49. Lee Y, Kwak S, Kim E, Kim S, Lee H, Chung Y, Jang B, Kim K, Kim J, Jo H, Kim E. Mobile monitoring system detects the disease activity pattern and shows the association with clinical outcomes in patients with newly diagnosed Crohn’s disease. Scientific Reports 2024;14(1) View